Build your own bundle and save up to 18%. Mix and match your Aeternum favourites: get 10% off 2 items, 15% off 3 items, or 18% off 4 or more items. Your favourites. Your bundle. Your savings.

Subscribe to get 20% OFF Promotion LIMITED TIME ONLY!


NMN and NAD+: What Human Studies Actually Tell Us

NMN and NAD+: What Human Studies Actually Tell Us

Understanding the Difference Between NMN and NAD+, How the Body Uses Them, and Whether Raising NAD+ Improves Health

NAD⁺ has become one of the most discussed molecules in healthy-aging research. It plays an essential role in cellular energy metabolism, DNA maintenance, and other processes that help cells function.

As researchers investigate how NAD⁺ changes with age, one compound has attracted particular attention: NMN (nicotinamide mononucleotide).

NMN is a precursor that the body can use to produce NAD⁺. Human studies have shown that oral NMN supplementation can increase certain NAD-related measurements in blood.

But there is an important question behind the growing interest:

If NMN increases NAD⁺ levels, does that automatically mean better health?

Not necessarily.

Raising a biological marker demonstrates that an ingredient is influencing a biological pathway. It does not automatically prove improvements in energy, physical performance, metabolic health, or longevity.

Let's explore how NMN and NAD⁺ are connected, what human clinical trials have actually found, and what the current evidence means when considering Aeternum NMN 500 mg Capsules.

1. What Is NAD+ and Why Does the Body Need It?

NAD⁺ stands for nicotinamide adenine dinucleotide.

It is a coenzyme found in virtually every living cell and is involved in hundreds of biological reactions.

One of its most important roles is helping cells convert nutrients into usable energy.

When you eat carbohydrates, fats, or proteins, your body breaks them down through metabolic pathways. NAD⁺ helps carry electrons during these reactions, supporting the processes that ultimately contribute to ATP production.

ATP, or adenosine triphosphate, is the molecule cells use to store and transfer energy.

However, NAD⁺ does more than participate in energy metabolism.

NAD+ and Cellular Maintenance

NAD⁺ is also used by enzymes involved in important cellular processes.

These include:

  • Sirtuins: A family of proteins involved in regulating cellular processes such as metabolism, stress responses, and gene expression.
  • PARPs: Enzymes involved in detecting and responding to DNA damage.
  • CD38: An enzyme that uses NAD⁺ in cellular signaling and other biological processes.

Because NAD⁺ participates in these different pathways, researchers are interested in understanding whether changes in its availability influence aspects of cellular function.

Does NAD+ Decline With Age?

Research suggests that NAD⁺ metabolism can change with age.

Some studies have reported lower NAD⁺ levels or altered NAD-related metabolites in certain tissues and populations.

However, the changes are not necessarily identical across every tissue or individual.

This is important because a blood NAD⁺ measurement does not automatically tell us what is happening inside every organ or cell.

The age-related changes in NAD⁺ metabolism have become an important reason researchers are investigating NAD⁺ precursors such as NMN and nicotinamide riboside (NR).

2. What Is NMN and How Is It Different From NAD+?

NMN stands for nicotinamide mononucleotide.

It is a naturally occurring molecule involved in the body's NAD⁺ production pathway.

The most important distinction is simple:

  • NMN is a precursor.
  • NAD⁺ is the coenzyme produced through the pathway.

NMN is not the same molecule as NAD⁺, and taking NMN does not mean you are directly consuming NAD⁺.

How Does NMN Become NAD+?

The body can produce NAD⁺ through several interconnected metabolic pathways.

One of these pathways involves NMN.

NMN is converted into NAD⁺ through an enzymatic reaction involving an enzyme called nicotinamide mononucleotide adenylyltransferase (NMNAT).

The enzyme helps combine NMN with ATP to produce NAD⁺.

This is why NMN is described as an NAD⁺ precursor.

The process is part of the body's normal NAD⁺ metabolism, rather than a direct transfer of NMN into a finished NAD⁺ molecule.

NMN vs. NAD+: What's the Difference?

Feature NMN NAD⁺
Full name Nicotinamide mononucleotide Nicotinamide adenine dinucleotide
Main role Precursor in NAD⁺ production Coenzyme involved in cellular reactions
Relationship Can be converted into NAD⁺ Produced through NAD⁺ biosynthesis pathways
Research interest Whether supplementation changes NAD-related biomarkers Cellular energy metabolism and maintenance processes

Understanding this relationship helps explain why researchers study NMN supplementation.

The goal is not simply to consume another molecule. It is to investigate whether providing a precursor can influence the body's NAD⁺ metabolism.

3. Why Are Researchers Studying NMN Supplementation?

Scientists are investigating NMN because NAD⁺ is involved in several biological processes that can change with age.

The research focuses on three major areas.

Cellular Energy Metabolism

NAD⁺ participates in metabolic reactions that help cells use nutrients to produce energy.

Researchers are investigating whether increasing NAD⁺ availability influences mitochondrial and metabolic function.

However, a higher NAD⁺ measurement does not automatically mean a person will feel more energetic.

DNA Damage Response

NAD⁺ is used by PARP enzymes, which participate in cellular responses to DNA damage.

Because DNA damage accumulates throughout life, researchers are interested in understanding how NAD⁺ availability relates to cellular maintenance.

This does not mean that NMN supplementation has been proven to repair DNA or prevent age-related diseases in humans.

Sirtuin Activity

Sirtuins are NAD⁺-dependent enzymes involved in regulating several cellular processes.

Their activity has been investigated in research on metabolism, stress responses, and aging.

However, it is important to distinguish between a biological pathway that depends on NAD⁺ and a demonstrated health benefit from taking an NMN supplement.

The fact that NAD⁺ is required for sirtuin activity does not establish that NMN supplementation improves longevity in people.

4. What Have Human Studies Found About NMN and NAD+ Levels?

One of the more consistent findings in human NMN research is that oral supplementation can increase NAD-related measurements in blood.

This is an important step because it demonstrates biological activity in humans.

But the amount of research and the results of individual trials still matter.

Here are several studies that help explain the current evidence.

Study 1: A 12-Week Trial in Older Adults

A randomized, double-blind, placebo-controlled study published in 2024 investigated NMN supplementation in older adults.

The trial included 60 participants who were assigned to receive either placebo or 250 mg of NMN daily for 12 weeks.

Researchers measured blood NAD-related metabolites, motor function, sleep, and other outcomes.

What did they find?

The NMN group showed significantly higher blood NAD⁺ and related metabolite levels after 12 weeks compared with placebo.

Researchers also reported:

  • A shorter four-meter walking time in the NMN group.
  • Improvements in selected sleep questionnaire scores.
  • No significant difference in the primary stepping-test outcome.
  • No adverse effects attributed to the study supplement during the intervention.

The distinction between primary and secondary outcomes matters.

The study's primary motor-function outcome did not show a significant difference. Some secondary outcomes did show differences favoring NMN.

This is encouraging preliminary evidence, but it does not establish that NMN improves physical function or sleep for everyone.

Research reference:

Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. (2024).

Read the full study.

Study 2: A 12-Week Trial in Middle-Aged Adults

Another randomized, double-blind, placebo-controlled study investigated NMN supplementation in 36 healthy middle-aged adults.

Participants received either placebo or 250 mg of NMN daily for 12 weeks.

Researchers examined NAD-related metabolites and arterial stiffness, measured using pulse wave velocity.

What did they find?

The study reported an increase in certain NAD-related metabolites, including serum nicotinamide, in the NMN group.

However, the difference in pulse wave velocity between the NMN and placebo groups was not statistically significant.

The researchers noted a tendency toward reduced arterial stiffness, but this should not be interpreted as proof of a cardiovascular benefit.

The study provides additional evidence that NMN can influence NAD⁺ metabolism, while demonstrating that improvements in a related physiological measurement are not guaranteed.

Research reference:

The Effects of Long-Term Nicotinamide Mononucleotide Supplementation on NAD+ Metabolism and Arterial Stiffness in Healthy Middle-Aged Adults. (2023).

Read the study on PubMed Central.

Study 3: A 14-Day Comparison of NAD+ Precursors

A randomized, placebo-controlled study published in Nature Metabolism in 2025 compared three NAD⁺ precursors:

  • Nicotinamide riboside (NR).
  • Nicotinamide mononucleotide (NMN).
  • Nicotinamide (NAM).

The trial enrolled 67 participants, who received one of the three compounds or placebo for 14 days.

The NMN group received 1,000 mg daily.

What did researchers find?

After 14 days, the NMN group showed an approximately twofold increase in baseline whole-blood NAD⁺ compared with placebo.

NR also increased whole-blood NAD⁺, while nicotinamide did not produce a statistically significant increase in the study's primary comparison.

This study is particularly useful because it directly compared different NAD⁺ precursors.

However, its primary focus was biochemical changes over 14 days, not long-term health outcomes.

It demonstrates that NMN can influence circulating NAD⁺ levels, not that it necessarily improves health or slows aging.

Research reference:

The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. (2025).

Read the study in Nature Metabolism.

Study 4: A 24-Week Trial in Older Adults

One of the more recent studies was published in npj Aging in September 2026.

Researchers investigated whether a higher daily dose of NMN could sustain increased NAD⁺ levels in older adults.

The randomized, double-blind, placebo-controlled study included participants aged 65 and older who received 1,250 mg of NMN daily or placebo for 24 weeks.

What did researchers find?

The NMN group showed significantly increased whole-blood NAD⁺ and related metabolites.

The intervention was generally well tolerated during the study, with no significant adverse effects reported.

However, researchers did not find significant improvements in:

  • The primary auditory-function outcome.
  • Physical-performance measurements.

Some changes in body composition, lipid-related measurements, and dietary behavior were observed, but they did not remain statistically significant after correction for multiple comparisons.

This is an especially useful study for understanding the difference between raising NAD⁺ and improving health.

Even when a relatively high NMN dose increased circulating NAD-related metabolites over 24 weeks, this did not translate into significant improvement in the primary functional outcomes measured.

Research reference:

Igarashi M, et al. (2026). Sustained NAD+ augmentation by high-dose nicotinamide mononucleotide supplementation in older adults: a 24-week randomized, double-blind, placebo-controlled trial.

Read the study in npj Aging.

5. If NMN Raises NAD+, Does That Automatically Mean Better Health?

No. This is the most important distinction in NMN research.

A biomarker is a measurable biological indicator. NAD⁺ levels are one example.

When researchers observe that NMN supplementation increases NAD⁺, they have evidence that the supplement influences the targeted biochemical pathway.

But that is only one part of evaluating whether a supplement produces meaningful health benefits.

Consider the difference:

Research finding What it tells us What it does not automatically prove
Increased blood NAD⁺ NMN influenced NAD-related metabolism Improved energy or longevity
Changes in NAD-related metabolites The body's metabolic response changed Better health in every organ
Changes in selected biomarkers Certain biological measurements changed Prevention of age-related disease
No significant adverse effects in a short trial No clear safety signal was detected during that study Long-term safety for everyone

A higher NAD⁺ level is scientifically relevant, but it should not be treated as a substitute for clinical outcomes.

Researchers still need to establish whether the biochemical changes lead to meaningful improvements in daily function, metabolic health, physical performance, or quality of life.

This is why the 2026 24-week study is particularly informative: it showed sustained NAD⁺ increases without significant improvement in its primary auditory or physical-performance outcomes.

6. What Does the Overall Human Evidence Say?

Individual clinical trials provide useful information, but systematic reviews help researchers understand the broader pattern.

A 2024 systematic review and meta-analysis examined randomized controlled trials of oral NMN supplementation and metabolic outcomes.

It included 12 studies involving a total of 513 participants.

The researchers found that NMN supplementation significantly increased blood NAD-related levels.

However, most of the evaluated glucose and lipid outcomes did not show significant differences between NMN and control groups.

This reinforces the distinction between biological activity and demonstrated clinical benefit.

What Does a 2026 Systematic Review Add?

A 2026 systematic review and meta-analysis examined 15 randomized trials of oral NMN or NMN-related preparations.

The included studies used daily amounts ranging from 250 mg to 2,000 mg, with durations ranging from 14 days to 24 weeks.

The review found that:

  • Short-term supplementation was generally well tolerated in the available trials.

  • There was no clear increase in overall or serious adverse events.

  • There was no significant improvement in several conventional metabolic outcomes, including fasting glucose, HbA1c, body weight, and lipid profiles.

  • Some preliminary signals were observed for diastolic blood pressure and insulin resistance measurements.

The authors emphasized that larger and longer studies are still needed to confirm efficacy and long-term safety.

Another 2026 systematic review of NAD⁺-related interventions similarly concluded that human studies consistently demonstrate biochemical changes, while effects on functional, metabolic, and other healthspan-related outcomes remain mixed.

What Can We Conclude?

The current human evidence supports three important points:

  1. Oral NMN can increase NAD-related biomarkers in humans.

  2. Short-term studies generally suggest reasonable tolerability in the populations studied.

  3. Evidence for consistent improvements in broader health outcomes remains inconclusive.

NMN is therefore an active area of clinical research, but it should not be described as a proven anti-aging treatment.

Research references:

  • Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: A systematic review with meta-analysis on randomized controlled trials. (2024). PubMed.
  • Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. (2026). Full study.
  • NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. (2026). Read the review.

7. What Questions Still Need to Be Answered?

Although human NMN research has expanded, several important questions remain.

Does Increasing Blood NAD+ Improve NAD+ Levels in Every Tissue?

Not necessarily.

Blood measurements do not automatically reflect NAD⁺ availability in every organ or cell type.

Researchers need to better understand how oral NMN influences tissue-specific NAD⁺ metabolism.

Do the Effects Last?

Many human studies have lasted only a few weeks or months.

Longer follow-up is needed to determine whether the biochemical changes remain with continued supplementation and what happens after supplementation stops.

Does NMN Improve Meaningful Health Outcomes?

Researchers need larger clinical trials that measure outcomes beyond NAD⁺ concentrations.

These may include physical function, metabolic health, cardiovascular measurements, and quality of life.

Who May Benefit Most?

Age, baseline NAD⁺ metabolism, nutritional status, and existing health conditions may influence individual responses.

Future research needs to identify whether certain groups respond differently to NMN supplementation.

What Is the Appropriate Dose?

Human trials have used a wide range of daily amounts.

There is currently no universally established dose that has been proven to produce specific anti-aging or longevity benefits.

These questions are important because the goal of supplementation research should be to understand meaningful health outcomes, not simply to increase a laboratory number.

8. Exploring Aeternum NMN 500 mg Capsules

For people interested in the research surrounding NAD⁺ metabolism, Aeternum offers NMN 500 mg Capsules.

The formulation features β-nicotinamide mononucleotide, the form of NMN investigated in many human supplementation studies.

According to Aeternum's current product listing, each capsule provides:

Product detail Information
Active ingredient β-Nicotinamide Mononucleotide (NMN)
Amount per capsule 500 mg
Listed purity At least 99%
Capsule shell Vegetable cellulose
Suggested use 1 capsule daily
Bottle options 60 or 180 capsules

The product listing also identifies the formulation as free from gluten, GMOs, dairy, soy, fillers, and artificial additives.

Aeternum provides access to product testing documentation, including information about ingredient identity and purity.

How Does the Formulation Relate to the Research?

The connection is the active ingredient: β-NMN.

Human clinical studies have investigated oral NMN at different daily amounts, including 250 mg, 500 mg, 1,000 mg, and higher doses.

Aeternum's formulation provides 500 mg per capsule.

However, the presence of the same ingredient does not mean that the branded product has been clinically tested in the studies discussed above.

The research involved specific study materials, dosing protocols, participants, and monitoring procedures.

Aeternum's product listing describes its own formulation and quality information, but the cited clinical trials do not establish the effectiveness of this particular product.

What Should You Review Before Choosing an NMN Supplement?

When evaluating an NMN formulation, consider:

  • The amount of β-NMN per capsule.
  • The stated ingredient purity.
  • The complete ingredient list.
  • Available third-party testing documentation.
  • The manufacturer's storage and usage instructions.
  • Current availability and shipping options in your region.

Understanding the formulation helps you make a more informed decision rather than relying only on broad NAD⁺ or anti-aging claims.

9. The Takeaway: Raising NAD+ Is Not the Same as Proving Better Health

NMN and NAD⁺ are closely connected, but they are not the same molecule.

NMN is a precursor that the body can use to produce NAD⁺, while NAD⁺ is a coenzyme involved in cellular energy metabolism and several maintenance pathways.

Human studies have consistently shown that oral NMN can increase NAD-related measurements in blood.

Some trials have also reported improvements in selected secondary outcomes, including walking speed and sleep measurements.

However, other studies have found no significant differences in primary functional outcomes, and systematic reviews have concluded that broader metabolic and health benefits remain uncertain.

The current evidence supports continued scientific interest in NMN, but it does not establish that increasing NAD⁺ through supplementation reverses aging, prevents disease, or extends human lifespan.

The most responsible approach is to understand the precursor relationship, examine the clinical evidence, and evaluate the actual formulation before making a decision.

Explore Aeternum NMN 500 mg Capsules

Interested in the science behind NAD⁺ metabolism?

Aeternum NMN provides 500 mg of β-nicotinamide mononucleotide per capsule, with product information and available testing documentation for customers to review.

If you are considering an NMN supplement, take a closer look at the ingredient amount, formulation, and quality information.

Discover Aeternum NMN

Explore the formulation and learn more about the ingredient being investigated in human NAD⁺ research.

EXPLORE AETERNUM NMN 500 MG CAPSULES

You can also review Aeternum's available product testing certificates.

Check the product page for current stock and shipping availability in your region before ordering.

Understand the science. Review the formulation. Make an informed decision about NMN.

Frequently Asked Questions

What is the difference between NMN and NAD+?

NMN is a precursor that the body can convert into NAD⁺. NAD⁺ is a coenzyme involved in cellular energy metabolism, DNA damage responses, and other biological processes.

Does NMN increase NAD+ levels?

Yes. Several human clinical trials have reported increased NAD⁺ or related metabolites in blood after oral NMN supplementation.

If NMN increases NAD+, does that mean it improves health?

Not automatically. Increased NAD⁺ is evidence of a biochemical effect, but it does not independently prove improvements in physical performance, metabolic health, disease prevention, or longevity.

What did the 2026 NMN clinical trial find?

A 24-week randomized trial in adults aged 65 and older found that 1,250 mg of NMN daily significantly increased whole-blood NAD⁺ and related metabolites. However, the study did not find significant improvements in its primary auditory-function outcome or physical-performance measures.

How long does NMN take to increase NAD+?

Some human studies have reported increased NAD-related measurements within two weeks. The timing and magnitude of changes depend on the study, dose, participant characteristics, and measurement method.

Is NMN the same as nicotinamide riboside (NR)?

No. NMN and NR are different NAD⁺ precursors. Both have been investigated in human studies, but they enter NAD⁺ metabolism through different biochemical steps.

Is NMN proven to slow aging?

No. NMN has demonstrated biological activity in human studies, but it has not been established as a treatment that reverses aging, prevents age-related diseases, or extends human lifespan.

How much NMN is in Aeternum's capsules?

Aeternum's current product listing specifies 500 mg of β-NMN per capsule, with a listed purity of at least 99%.

Is NMN safe for everyone?

Short-term human trials generally report reasonable tolerability, but long-term safety is not fully established. People who are pregnant or breastfeeding, under 18, taking medication, or managing a medical condition should consult a qualified healthcare professional before considering supplementation.

Scientific References

  1. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. (2024). Full study.
  2. The Effects of Long-Term Nicotinamide Mononucleotide Supplementation on NAD+ Metabolism and Arterial Stiffness in Healthy Middle-Aged Adults. (2023). Full study.
  3. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. (2025). Nature Metabolism.
  4. Igarashi M, et al. (2026). Sustained NAD+ augmentation by high-dose nicotinamide mononucleotide supplementation in older adults: a 24-week randomized, double-blind, placebo-controlled trial. npj Aging.
  5. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: A systematic review with meta-analysis on randomized controlled trials. (2024). PubMed.
  6. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. (2026). Full study.
  7. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. (2026). Ageing Research Reviews.

Disclaimer: This article is for educational purposes only and is not medical advice. NMN has not been established as a treatment for aging or any medical condition. Increases in NAD⁺ biomarkers do not guarantee improvements in energy, physical performance, metabolic health, or lifespan. Human studies to date have generally been short-term, and long-term safety and clinical benefits require further investigation. Consult a qualified healthcare professional before using supplements, particularly if you take medication, have an existing medical condition, or are pregnant or breastfeeding.